[link] Nagata M, Yamamoto N, Miyamoto T, Shimomura A, Arima S, Hirsch AM, Suzuki A
How to Prepare for a Dose Increase Preparing for a dose increase can reduce side effects and make the transition smoother
PMID: 17498508 DOI: 10.1053/j.gastro.2007.03.054 Boer GA et al (2023): Obesity pharmacotherapy: incretin action in the central nervous system
Here is my clinical translation: Do not stop GLP-1 medications out of fear of muscle wasting
Discussion While it is well accepted that EtOH-associated oxidative stress is a key mediator in the pathogenesis of ALD, the molecular details governing this process remain incompletely understood
This mechanism has been shown to alleviate long-term behavioral deficits associated with ketamine treatment in a preclinical SZ model during the perinatal period (Neill et al., 2022